Ovid Therapeutics Inc.
OVID · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$26,433 | -$52,339 | -$54,169 | $119,839 |
| Dep. & Amort. | $613 | $1,597 | $1,382 | $237 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6,276 | $7,285 | $6,557 | $0 |
| Change in WC | -$150 | $2,386 | -$8,231 | -$16,814 |
| Other Non-Cash | -$36,262 | -$4,709 | -$765 | $15,350 |
| Operating Cash Flow | -$55,956 | -$45,781 | -$55,227 | $118,612 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$71 | -$40 | -$1,419 | -$189 |
| Net Acquisitions | $0 | -$10,000 | -$2,500 | $0 |
| Inv. Purchases | -$73,246 | -$112,443 | -$172,964 | -$1,632 |
| Inv. Sales/Matur. | $128,000 | $120,000 | $90,000 | $0 |
| Other Inv. Act. | -$89 | -$97 | -$1,000 | $0 |
| Investing Cash Flow | $54,594 | -$2,581 | -$87,883 | -$1,821 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $30,000 | $0 | $0 |
| Stock Issued | $622 | $535 | $181 | $925 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$21 |
| Financing Cash Flow | $622 | $30,535 | $181 | $904 |
| Forex Effect | $0 | $0 | $0 | -$1,931 |
| Net Chg. in Cash | -$740 | -$17,826 | -$142,930 | $115,764 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $28,972 | $46,799 | $189,728 | $72,034 |
| End Cash | $28,232 | $28,972 | $46,799 | $187,798 |
| Free Cash Flow | -$56,027 | -$45,918 | -$56,646 | $118,428 |